The AIM-HIGH trial showed significant DFS improvement in high-risk stage 1a to 2a nonsquamous NSCLC patients receiving adjuvant chemotherapy. At 24 months, 96% of chemotherapy patients were alive ...
Lung cancer is the leading cause of cancer death in Indiana. High smoking rates, exposure to radon and low screening rates ...
Please provide your email address to receive an email when new articles are posted on . Surgery and stereotactic ablative radiotherapy conferred comparable 10-year survival among patients with ...
The 2025 “State of Lung Cancer” report from the American Lung Association once again ranks Kentucky as first in the nation in ...
The Chosun Ilbo on MSN
Non-Smoker Lung Cancer Surge, Rycarza Effective for Brain Metastasis
According to the latest statistics from the Ministry of Data and Statistics, 21.9% of cancer-related deaths are attributed to ...
A protein involved with cell death can be manipulated to slow or reverse tumor growth, a pair of new studies in mice found.
An objective response rate of 48.2% was observed with ifinatamab deruxtecan in these previously treated patients Discussions with global regulatory authorities underway Results from the IDeate-Lung01 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback